These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 7520014)

  • 41. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma.
    Sasaki K; Matsuda M; Ohkura Y; Kawamura Y; Inoue M; Hashimoto M; Ikeda K; Kumada H; Watanabe G
    Surgery; 2015 Feb; 157(2):223-30. PubMed ID: 25616938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK
    Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical management for adrenal gland metastasis of hepatocellular carcinoma.
    Sakamoto Y; Kubota K; Mori M; Inoue K; Abe H; Harihara Y; Bandai Y; Makuuchi M
    Hepatogastroenterology; 1999; 46(26):1036-41. PubMed ID: 10370663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
    Cheema AW; Hirschtritt T; Van Thiel DH
    Hepatogastroenterology; 2004; 51(60):1676-8. PubMed ID: 15532803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
    Marubashi S; Dono K; Nagano H; Sugita Y; Asaoka T; Hama N; Miyamoto A; Takeda Y; Umeshita K; Monden M
    Transpl Int; 2007 Jul; 20(7):576-82. PubMed ID: 17425725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
    Jeng KS; Sheen IS; Tsai YC
    Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
    Tanwandee T; Setthasin S; Charatcharoenwitthaya P; Chainuvati S; Leelakusolvong S; Pausawasdi N; Srikureja W; Pongprasobchai S; Manatsathit S; Kachintorn U; Ekpo P; Senawong S
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S49-56. PubMed ID: 19562986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
    Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Postoperative detection of AFP mRNA in the peripheral blood of hepatic cellular carcinoma patients and its correlation with recurrence].
    Zhi H; Zhan J; Deng QL; Huang ZM
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):112-5. PubMed ID: 17645845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alpha-fetoprotein secreting adrenal metastasis after hepatectomy for non-secreting hepatocarcinoma. Description of a case].
    De Santis M; Cristani A; Cioni G; Montanari N
    Radiol Med; 1993 Mar; 85(3):287-8. PubMed ID: 7684142
    [No Abstract]   [Full Text] [Related]  

  • 55. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
    Li SP; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
    J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
    Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
    Funaki NO; Tanaka J; Seto SI; Kasamatsu T; Kaido T; Imamura M
    Hepatology; 1997 Mar; 25(3):564-8. PubMed ID: 9049199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.